Tonix - A Single-blind, Randomized Study Comparing the Efficacy and Safety of A Single Dose of TNX-1300 to Placebo with Usual Care (UC) for the Treatment of Signs and Symptoms of Acute Cocaine Intoxication in Emergency Department (ED) Subjects

Grants and Contracts Details

StatusActive
Effective start/end date1/9/24 → 1/9/26

Funding

  • Tonix Pharmaceuticals Incorporated: $58,389.00